The evolving role of investigative toxicology in the pharmaceutical industry

F Pognan, M Beilmann, HCM Boonen… - Nature reviews drug …, 2023 - nature.com
For decades, preclinical toxicology was essentially a descriptive discipline in which
treatment-related effects were carefully reported and used as a basis to calculate safety …

Precision medicine in human heart modeling: Perspectives, challenges, and opportunities

M Peirlinck, FS Costabal, J Yao, JM Guccione… - … and modeling in …, 2021 - Springer
Precision medicine is a new frontier in healthcare that uses scientific methods to customize
medical treatment to the individual genes, anatomy, physiology, and lifestyle of each person …

Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications

S Min, S Kim, WS Sim, YS Choi, H Joo, JH Park… - Nature …, 2024 - nature.com
Engineered human cardiac tissues have been utilized for various biomedical applications,
including drug testing, disease modeling, and regenerative medicine. However, the …

The 'Digital Twin'to enable the vision of precision cardiology

J Corral-Acero, F Margara, M Marciniak… - European heart …, 2020 - academic.oup.com
Providing therapies tailored to each patient is the vision of precision medicine, enabled by
the increasing ability to capture extensive data about individual patients. In this position …

International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment

K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo… - Cell reports, 2018 - cell.com
To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-
CMs) as an in vitro proarrhythmia model, we evaluated the concentration dependence and …

Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity

E Passini, OJ Britton, HR Lu, J Rohrbacher… - Frontiers in …, 2017 - frontiersin.org
Early prediction of cardiotoxicity is critical for drug development. Current animal models
raise ethical and translational questions, and have limited accuracy in clinical risk prediction …

[HTML][HTML] An evaluation framework for new approach methodologies (NAMs) for human health safety assessment

ST Parish, M Aschner, W Casey, M Corvaro… - Regulatory Toxicology …, 2020 - Elsevier
The need to develop new tools and increase capacity to test pharmaceuticals and other
chemicals for potential adverse impacts on human health and the environment is an active …

Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias

K Blinova, J Stohlman, J Vicente, D Chan… - Toxicological …, 2017 - academic.oup.com
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) hold promise for
assessment of drug-induced arrhythmias and are being considered for use under the …

Nanocrown electrodes for parallel and robust intracellular recording of cardiomyocytes

Z Jahed, Y Yang, CT Tsai, EP Foster… - Nature …, 2022 - nature.com
Drug-induced cardiotoxicity arises primarily when a compound alters the
electrophysiological properties of cardiomyocytes. Features of intracellular action potentials …

Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment

S Dutta, KC Chang, KA Beattie, J Sheng… - Frontiers in …, 2017 - frontiersin.org
Drug-induced Torsade-de-Pointes (TdP) has been responsible for the withdrawal of many
drugs from the market and is therefore of major concern to global regulatory agencies and …